TWI878203B - 包含pedf-衍生之短肽之組合物及其用途 - Google Patents

包含pedf-衍生之短肽之組合物及其用途 Download PDF

Info

Publication number
TWI878203B
TWI878203B TW106133749A TW106133749A TWI878203B TW I878203 B TWI878203 B TW I878203B TW 106133749 A TW106133749 A TW 106133749A TW 106133749 A TW106133749 A TW 106133749A TW I878203 B TWI878203 B TW I878203B
Authority
TW
Taiwan
Prior art keywords
pdsp
peptide
seq
pharmaceutical composition
cells
Prior art date
Application number
TW106133749A
Other languages
English (en)
Chinese (zh)
Other versions
TW201822785A (zh
Inventor
文機 李
林冠吟
曹友平
何宗權
Original Assignee
全福生物科技股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 全福生物科技股份有限公司 filed Critical 全福生物科技股份有限公司
Publication of TW201822785A publication Critical patent/TW201822785A/zh
Application granted granted Critical
Publication of TWI878203B publication Critical patent/TWI878203B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
TW106133749A 2016-10-07 2017-09-29 包含pedf-衍生之短肽之組合物及其用途 TWI878203B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662405522P 2016-10-07 2016-10-07
US62/405,522 2016-10-07

Publications (2)

Publication Number Publication Date
TW201822785A TW201822785A (zh) 2018-07-01
TWI878203B true TWI878203B (zh) 2025-04-01

Family

ID=61831898

Family Applications (1)

Application Number Title Priority Date Filing Date
TW106133749A TWI878203B (zh) 2016-10-07 2017-09-29 包含pedf-衍生之短肽之組合物及其用途

Country Status (10)

Country Link
US (1) US11760784B2 (enExample)
EP (1) EP3596104A4 (enExample)
JP (2) JP7573967B2 (enExample)
KR (2) KR20230169375A (enExample)
CN (1) CN110312732A (enExample)
AU (2) AU2017340245B2 (enExample)
EA (1) EA037698B1 (enExample)
IL (1) IL265796B2 (enExample)
TW (1) TWI878203B (enExample)
WO (2) WO2018067244A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA202092366A1 (ru) * 2018-04-08 2021-01-26 Брим Байотекнолоджи, Инк. Применение происходящих из pedf коротких пептидов при лечении остеоартрита
EP3761959A4 (en) * 2018-04-08 2022-03-02 Brim Biotechnology, Inc. APPLICATION OF PEDF DERIVED SHORT PEPTIDES IN TENDON HEALING
US20210128685A1 (en) * 2018-05-04 2021-05-06 Brim Biotechnology, Inc. Pedf-derived peptides for promoting meibomian gland regeneration and uses thereof
CN111632128B (zh) * 2019-02-14 2022-07-05 三凡生技研发股份有限公司 短链胜肽组合物在预防或治疗干眼症的应用
TWI759610B (zh) * 2019-06-27 2022-04-01 晶碩光學股份有限公司 具有角膜修護功能的眼用產品
AU2019463840B2 (en) * 2019-08-27 2023-03-09 Mackay Memorial Hospital Short synthetic peptide and their uses for treating retinal degenerative diseases and/or tissue injuries
TWI744683B (zh) * 2019-08-27 2021-11-01 台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院 短合成胜肽及其治療視網膜退化性疾病和/或組織損傷的用途
JP2022550907A (ja) * 2019-10-06 2022-12-05 ブリム バイオテクノロジー インク Ｐｅｄｆ由来短ペプチド（ｐｄｓｐ）を含む組成物及びその使用
CN112206312A (zh) * 2020-11-19 2021-01-12 北京大学第三医院（北京大学第三临床医学院） 一种包含pedf的用于治疗干眼的药物组合物
CN115364199A (zh) * 2021-05-19 2022-11-22 远大医药（中国）有限公司 包含pedf衍生的短肽的组合物及其制备方法和用途
AU2023292282A1 (en) * 2022-06-13 2025-01-23 Brim Biotechnology, Inc. Compositions comprising pedf-derived short peptides for the treatment of dry eye diseases
TW202400628A (zh) * 2022-06-24 2024-01-01 全福生物科技股份有限公司 用於治療神經營養性角膜炎疾病之包含pedf衍生短肽之組合物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2508196A1 (en) * 2011-03-23 2012-10-10 Mackay Memorial Hospital Use of PEDF-derived polypeptides for promoting stem cells proliferation and wound healing
US20150079094A1 (en) * 2013-09-13 2015-03-19 The Penn State Research Foundation Functional Peptide Analogs of PEDF

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6451763B1 (en) * 1992-06-04 2002-09-17 The United States Of America As Represented By The Department Of Health And Human Services Retinal pigmented epithelium derived neurotrophic factor and methods of use
US6797691B1 (en) * 1997-07-23 2004-09-28 Northwestern University Methods and compositions for inhibiting angiogenesis
JP2007509984A (ja) * 2003-10-29 2007-04-19 ザ・ジョンズ・ホプキンス・ユニバーシティ 色素上皮由来因子、その新規な生物活性及びその使用方法
US20050260180A1 (en) * 2004-03-12 2005-11-24 Genvec, Inc. Materials and methods for treating vascular leakage in the eye
US20090069241A1 (en) * 2006-02-15 2009-03-12 Yale University Compositions and Methods for Use of Pigment Epithelial Derived Factor (PEDF) Peptide Fragments
BRPI0911501A2 (pt) * 2008-04-29 2015-07-28 Monsanto Technology Llc Genes e usos para melhoramento de plantas.
JP2013507373A (ja) * 2009-10-08 2013-03-04 ニューロテック ユーエスエー， インコーポレイテッド 被包された細胞ベースの送達系におけるｐｅｄｆの使用
TWI554521B (zh) * 2011-10-19 2016-10-21 台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院 色素上皮衍生因子衍生之多胜肽於治療禿髮和／或毛髮脫色之用途
KR101801198B1 (ko) * 2012-08-09 2017-11-24 맥케이 메모리얼 호스피탈 근육 또는 힘줄 재생 또는 동맥형성을 촉진하기 위해 사용되는 pedf-유도 폴리펩티드의 용도
US9815878B2 (en) * 2012-09-19 2017-11-14 Mackay Memorial Hospital Use of PEDF-derived polypeptides for preventing and/or ameliorating skin aging
CN104903344B (zh) * 2012-09-20 2018-09-04 财团法人台湾基督长老教会马偕纪念社会事业基金会马偕纪念医院 Pedf衍生的多肽在治疗骨关节炎中的用途

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2508196A1 (en) * 2011-03-23 2012-10-10 Mackay Memorial Hospital Use of PEDF-derived polypeptides for promoting stem cells proliferation and wound healing
US20150079094A1 (en) * 2013-09-13 2015-03-19 The Penn State Research Foundation Functional Peptide Analogs of PEDF

Also Published As

Publication number Publication date
EA201990885A1 (ru) 2019-08-30
WO2018067217A3 (en) 2019-05-02
JP2022185042A (ja) 2022-12-13
IL265796A (en) 2019-06-30
WO2018067244A1 (en) 2018-04-12
KR20190066030A (ko) 2019-06-12
IL265796B1 (en) 2024-10-01
AU2017340245A1 (en) 2019-05-23
JP7573967B2 (ja) 2024-10-28
AU2017340245B2 (en) 2022-07-21
EP3596104A4 (en) 2021-02-17
JP2019533722A (ja) 2019-11-21
EP3596104A1 (en) 2020-01-22
IL265796B2 (en) 2025-02-01
US11760784B2 (en) 2023-09-19
TW201822785A (zh) 2018-07-01
WO2018067217A2 (en) 2018-04-12
KR20230169375A (ko) 2023-12-15
EA037698B1 (ru) 2021-05-12
US20190248859A1 (en) 2019-08-15
CN110312732A (zh) 2019-10-08
AU2022204557A1 (en) 2022-07-21

Similar Documents

Publication Publication Date Title
TWI878203B (zh) 包含pedf-衍生之短肽之組合物及其用途
US20240123032A1 (en) Compositions and methods for prevention and treatment of corneal haze and scarring
JP6612247B2 (ja) 眼の感染症および疾患を処置するための組成物および方法
Zhou et al. Rosmarinic acid-grafted gelatin nanogels for efficient diquafosol delivery in dry eye disease therapy
WO2025162442A9 (zh) Kgf-2在治疗干眼症中的应用
JP2024059784A (ja) マイボーム腺再生を促進するためのｐｅｄｆ由来ペプチドおよびその使用
El-Shazly et al. Comparison between two cyclooxygenase inhibitors in an experimental dry eye model in albino rabbits
JP2019525923A (ja) ドライアイ症候群を治療する方法
TW202228726A (zh) 一種醫藥組合物用於製備眼表損傷之藥物的用途
WO2016009982A1 (ja) 角結膜障害治療剤
JP7353548B2 (ja) 網膜変性疾患及び／又は組織傷害を処置するための短鎖合成ペプチド及びその使用
US20180256690A1 (en) Protection and sealing of the ocular surface barrier by clusterin
JP2025181979A (ja) 角膜の混濁および瘢痕化の予防および治療のための組成物および方法
Ratay Controlled Release of an HDAC Inhibitor for Reduction of Inflammation in Dry Eye Disease Michelle L. Ratay, Stephen C. Balmert, Ethan J. Bassin c, and Steven R. Little